16-88438265-G-T
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_001367624.2(ZNF469):c.10795G>T(p.Ala3599Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000729 in 1,548,214 control chromosomes in the GnomAD database, including 13 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/17 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_001367624.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZNF469 | NM_001367624.2 | c.10795G>T | p.Ala3599Ser | missense_variant | 3/3 | ENST00000565624.3 | NP_001354553.1 | |
ZNF469 | XM_047434810.1 | c.10795G>T | p.Ala3599Ser | missense_variant | 4/4 | XP_047290766.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZNF469 | ENST00000565624.3 | c.10795G>T | p.Ala3599Ser | missense_variant | 3/3 | NM_001367624.2 | ENSP00000456500 | A2 | ||
ZNF469 | ENST00000437464.1 | c.10711G>T | p.Ala3571Ser | missense_variant | 2/2 | 5 | ENSP00000402343 | P4 |
Frequencies
GnomAD3 genomes AF: 0.00399 AC: 607AN: 152118Hom.: 6 Cov.: 34
GnomAD3 exomes AF: 0.000762 AC: 115AN: 150882Hom.: 3 AF XY: 0.000533 AC XY: 43AN XY: 80660
GnomAD4 exome AF: 0.000374 AC: 522AN: 1395976Hom.: 7 Cov.: 92 AF XY: 0.000298 AC XY: 205AN XY: 688122
GnomAD4 genome AF: 0.00398 AC: 606AN: 152238Hom.: 6 Cov.: 34 AF XY: 0.00380 AC XY: 283AN XY: 74414
ClinVar
Submissions by phenotype
not provided Benign:5
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Sep 12, 2019 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics | Feb 16, 2017 | - - |
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Mar 01, 2023 | ZNF469: BP4, BS1, BS2 - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Jun 03, 2015 | - - |
Cardiovascular phenotype Benign:1
Benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 07, 2020 | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Brittle cornea syndrome 1 Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Dec 05, 2021 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at